|
| Catalog Number | Size | Price (USD) | Shopping Cart |
|---|---|---|---|
| PR27023-2 | 2 ug | $85.00 | Buy Now | Add to Cart |
| PR27023-10 | 10 ug | $195.00 | Buy Now | Add to Cart |

BMP-2 belongs to the Bone-growth regulatory factors that are members of the transforming growth factor-beta (TGF-beta) superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins. .
Image: BMP-2 protein structure and sequence
References:
1. Effect of recombinant human bone morphogenetic protein-2 on mandibular distraction at different rates in a rabbit model. Tissue Eng 2006 Nov;12(11):3181-8
2. Skull bone regeneration in nonhuman primates by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 2007 Feb;13(2):293-300
3. The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: an animal experiment. Spine 2007 May 15;32(11):1174-80
4. The effect of recombinant human bone morphogenetic protein-2 on the osteogenic potential of rat mesenchymal stem cells after several passages. Acta Orthop 2007 Apr;78(2):285-92
5. Bone morphogenetic protein-2/4 signalling pathway components are expressed in the human thymus and inhibit early T-cell development. Immunology 2007 May;121(1):94-104
6. Re: Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006; 31:2534-40. Spine 2007 Mar 15;32(6):708; author reply 708








